the role of small nucleotide, copy number and structural variants in extramedullary myeloma
Published 1 year ago • 32 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
0:58
minimumm-seq: a novel, minimally invasive approach to characterize myeloma pathology
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
0:59
defining the origins of multiple myeloma
-
3:30
balkan myeloma study group: extramedullary disease
-
5:17
the evolving role of autologous transplantation in multiple myeloma
-
3:37
smoldering myeloma: state of the art
-
2:57
comprehensive detection of myeloma genomic abnormalities
-
21:38
drawing the line: the rationale behind blood tube collection order
-
6:32
a phase i trial of dsp-5336, a novel menin inhibitor, in the treatment of aml
-
3:12
updated results of the linker-mm1 trial: linvoseltamab in r/r multiple myeloma
-
1:57
the role of selinexor in the context of novel immune therapies in r/r multiple myeloma
-
3:17
locommotion: analysis of soc for r/r myeloma
-
3:08
real-world data modeling to evaluate cilta-cel in second vs third-line for refractory myeloma
-
1:33
circulating tumor cells in multiple myeloma
-
1:13
using integrative multiomics to explain myeloma progression and evolution of refractory disease
-
2:56
novel drugs for myeloma thromboprophylaxis
-
1:26
braf-mutated aml is associated with poor prognosis and myelodysplasia-related mutations
-
3:00
processes leading to the development of hyperdiploidy in multiple myeloma
-
2:20
novel technologies and the prognostic value of identifying subclones in myeloma
-
6:58
current treatments and sequencing of agents in multiple myeloma
-
5:35
genetic profiling of multiple myeloma in the novel agents era